Effectiveness and safety of a novel gel dressing in the management of neuropathic leg ulcers in diabetic patients: A prospective double-blind randomized trial

International Journal of Lower Extremity Wounds

Volumn 8, Issue 3, 2009, Pages 134-140

  Abbruzzese, L ^a   Rizzo, L ^a   Fanelli, G ^a   Tedeschi, A ^a   Scatena, A ^a   Goretti, C ^a   MacChiarini, S ^a   Piaggesi, A ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

Aminoacids; Diabetes; Gel; Ulceration; Wound healing

Indexed keywords

AMINO ACID; GLYCINE; HYALURONIC ACID; LEUCINE; LYSINE; POLYURETHAN; PROLINE; UNCLASSIFIED DRUG; VULNAMIN;

ADULT; ARTICLE; BANDAGE; CHRONIC DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC NEUROPATHY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG FORMULATION; DRUG SAFETY; FEMALE; GEL; GRANULATION TISSUE; HUMAN; INFECTIOUS COMPLICATION; LEG COMPRESSION; LEG EDEMA; LEG ULCER; MALE; NEUROPATHIC LEG ULCER; PAIN; PATIENT SATISFACTION; PERIPHERAL NEUROPATHY; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SKIN SENSITIZATION; TREATMENT OUTCOME; VISUAL ANALOG SCALE; WOUND DRESSING; WOUND HEALING;

ADMINISTRATION, TOPICAL; AMINO ACIDS; BANDAGES; DIABETIC NEUROPATHIES; DOUBLE-BLIND METHOD; DRUG COMBINATIONS; FOLLOW-UP STUDIES; GELS; HUMANS; HYALURONIC ACID; LEG ULCER; MIDDLE AGED; PROSPECTIVE STUDIES; TREATMENT OUTCOME; WOUND HEALING;

EID: 69449105981     PISSN: 15347346     EISSN: 15526941     Source Type: Journal    
DOI: 10.1177/1534734609344140     Document Type: Article

References (31)

1. Reiberg GE, Boyko EJ, Smith DG Lower extremity foot ulcers and amputations in diabetes. In: National Diabetes Data Group, ed. Diabetes in America. 2 nd ed. Washington, DC: National Institutes of Health ; 1995: 409-428.
2. Boulton AJ, Vileikyte L., Ragnarson-Tennvall G., Apelqvist J. The global burden of diabetic foot disease. Lancet. 2005 ; 366: 1719-1724.
3. Centers for Disease Control & Prevention. Lower extremity disease among persons aged > or = 40 years with or without diabetes-United States 1999-2002. MMWR Morb Mortal Wkly Rep. 2005 ; 54: 1158-1160.
4. Urbancic-Rovan V. Causes of diabetic foot lesions. Lancet. 2005 ; 366: 1675-1676.
5. Boulton AJ The diabetic foot: from art to science. The 18th Camillo Golgi lecture. Diabetologia. 2004 ; 47: 1343-1353.
6. Litzelman DK, Marriott DJ, Vinicor F. Independent physiological predictors of foot lesions in patients with NIDDM. Diabetes Care. 1997 ; 20: 1273-1278.
7. Rayman G., Hassan A., Tooke JE Blood flow in the skin of the foot related to posture in diabetes mellitus. Br Med J (Clin Res Ed). 1986 ; 292: 87-90.
8. Cacciatori V., Dellera A., Bellavere F., et al. Comparative assessment of peripheral sympathetic function by postural vasoconstriction arteriolar reflex and sympathetic skin response in NIDDM patients. Am J Med. 1997 ; 102: 365-370.
9. Purewal TS, Goss DE, Watkins PJ, Edmonds ME Lower limb venous pressure in diabetic neuropathy. Diabetes Care. 1995 ; 18: 377-381.
10. Reinhardt F., Wetzel T., Vetten S., et al. Peripheral neuropathy in chronic venous insufficiency. Muscle Nerve. 2000 ; 23: 883-887.
11. Uccioli L., Mancini L., Giordano A., et al. Lower limb arteriovenous shunts, autonomic neuropathy and diabetic foot. Diabetes Res Clin Pract. 1992 ; 16: 123-130.
12. Brem H., Tomic-Canic M., Tarnovskaya A., et al. Healing of elderly patients with diabetic foot ulcers, venous stasis ulcers, and pressure ulcers. Surg Technol Int. 2003 ; 11: 161-167.
13. Bowering CK Use of layered compression bandages in diabetic patients. Experience in patients with lower leg ulceration, peripheral edema, and features of venous and arterial disease. Adv Wound Care. 1998 ; 11: 129-135.
14. Falanga V. Wound healing and its impairment in the diabetic foot. Lancet. 2005 ; 366: 1736-1743.
15. Loots MA, Lamme EN, Zeegelaar J., Mekkes JR, Bos JD, Middelkoop E. Differences in cellular infiltrate and extracellular matrix of chronic diabetic and venous ulcers versus acute wounds. J Invest Dermatol. 1998 ; 111: 850-857.
16. Favia G., Mariggio MA, Maiorano F., Cassano A., Capodiferro S., Ribatti D. Accelerated wound healing of oral soft tissues and angiogenic effect induced by a pool of aminoacids combined to sodium hyaluronate. J Biol Regul Homeost Agents. 2008 ; 22: 109-116.
17. Allison DD, Grande-Allen KJ Review. Hyaluronan: a powerful tissue engineering tool. Tissue Eng. 2006 ; 12: 2131-2140.
18. Price RD, Myers S., Leigh IM, Navsaria HA The role of hyaluronic acid in wound healing: assessment of clinical evidence. Am J Clin Dermatol. 2005 ; 6: 393-402.
19. Gundersen Y., Vaagenes P., Os Ø, Pillgram-Larsen J., Sundnes KO, Opstad PK Capacity of glycine to modulate early inflammatory disturbances after serious gunshot injuries in the pig. Scand J Clin Lab Invest. 2007 ; 67: 143-153.
20. Bao F., John SM, Chen Y., Mathison RD, Weaver LC The tripeptide phenylalanine-(D) glutamate-(D) glycine modulates leukocyte infiltration and oxidative damage in rat injured spinal cord. Neuroscience. 2006 ; 140: 1011-1022.
21. Cruz M., Maldonado-Bernal C., Mondragn-Gonzalez R., et al. Glycine treatment decreases proinflammatory cytokines and increases interferon-gamma in patients with type 2 diabetes. J Endocrinol Invest. 2008 ; 31: 694-699.
22. Anbanandam A., Albarado DC, Tirziu DC, Simons M., Veeraraghavan S. Molecular basis for proline- and arginine-rich peptide inhibition of proteasome. J Mol Biol. 2008 ; 384: 219-227.
23. Kessler L., Piemont Y., Ortega F., et al. Comparison of microbiological results of needle puncture vs. superficial swab in infected diabetic foot ulcer with osteomyelitis. Diabet Med. 2006 ; 23: 99-102.
24. Pellizzer G., Strazzabosco M., Presi S., et al. Deep tissue biopsy vs. superficial swab culture monitoring in the microbiological assessment of limb-threatening diabetic foot infection. Diabet Med. 2001 ; 18: 822-827.
25. Dale JJ, Ruckley CV, Gibson B., Brown D., Lee AJ, Prescott RJ Multi-layer compression: comparison of four different four-layer bandage systems applied to the leg. Eur J Vasc Endovasc Surg. 2004 ; 27: 94-99.
26. Loots MA, Lamme EN, Mekkes JR, Bos JD, Middelkoop E. Cultured fibroblasts from chronic diabetic wounds on the lower extremity (non-insulin-dependent diabetes mellitus) show disturbed proliferation. Arch Dermatol Res. 1999 ; 291: 93-99.
27. Black E., Vibe-Petersen J., Jorgensen LN, et al. Decrease of collagen deposition in wound repair in type 1 diabetes independent of glycemic control. Arch Surg. 2003 ; 138: 34-40.
28. Doshi BM, Perdrizet GA, Hightower LE Wound healing from a cellular stress response perspective. Cell Stress Chaperones. 2008 ; 13: 393-399.
29. Sheehan P., Jones P., Caselli A., Giurini JM, Veves A. Percent change in wound area of diabetic foot ulcers over a 4-week period is a robust predictor of complete healing in a 12-week prospective trial. Diabetes Care. 2003 ; 26: 1879-1882.
30. Roy S., Khanna S., Nallu K., Hunt TK, Sen CK Dermal wound healing is subject to redox control. Mol Ther. 2006 ; 13: 211-220.
31. Sen CK, Khanna S., Babior BM, Hunt TK, Ellison EC, Roy S. Oxidant-induced vascular endothelial growth factor expression in human keratinocytes and cutaneous wound healing. J Biol Chem. 2002 ; 277: 33284-33290.